Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia
Αποθετήριο DSpace/Manakin
JavaScript is disabled for your browser. Some features of this site may not work without it.
Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia
Tsimberidou, AM; Stavroyianni, N; Viniou, N; Papaioannou, M; Tiniakou, M; Marinakis, T; Skandali, A; Sakellari, L; Yataganas, X